These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6469997)

  • 41. The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen.
    Cole WG; Patterson E; Bonadio J; Campbell PE; Fortune DW
    J Med Genet; 1992 Feb; 29(2):112-8. PubMed ID: 1613761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Wallis GA; Starman BJ; Zinn AB; Byers PH
    Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A structural mutation of the collagen alpha 1(I)CB7 peptide in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    J Biol Chem; 1987 Apr; 262(10):4445-51. PubMed ID: 3558348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered helical structure of a homotrimer of alpha 1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta.
    Deak SB; van der Rest M; Prockop DJ
    Coll Relat Res; 1985 Sep; 5(4):305-13. PubMed ID: 4053561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.
    Valli M; Sangalli A; Rossi A; Mottes M; Forlino A; Tenni R; Pignatti PF; Cetta G
    Eur J Biochem; 1993 Feb; 211(3):415-9. PubMed ID: 7679635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.
    Nicholls AC; Oliver J; Renouf DV; Keston M; Pope FM
    J Med Genet; 1991 Nov; 28(11):757-64. PubMed ID: 1770532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A heterozygous defect for structurally altered pro-alpha 2 chain of type I procollagen in a mild variant of osteogenesis imperfecta. The altered structure decreases the thermal stability of procollagen and makes it resistant to procollagen N-proteinase.
    Sippola M; Kaffe S; Prockop DJ
    J Biol Chem; 1984 Nov; 259(22):14094-100. PubMed ID: 6438090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
    Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW
    J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.
    Baldwin CT; Constantinou CD; Dumars KW; Prockop DJ
    J Biol Chem; 1989 Feb; 264(5):3002-6. PubMed ID: 2914942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
    Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain.
    Torre-Blanco A; Adachi E; Romanic AM; Prockop DJ
    J Biol Chem; 1992 Mar; 267(7):4968-73. PubMed ID: 1537873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
    Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
    J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cysteine in the triple helical domain of the pro alpha 2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta.
    Cohn DH; Byers PH
    Hum Genet; 1991 Jun; 87(2):167-72. PubMed ID: 2066103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
    J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.
    Superti-Furga A; Pistone F; Romano C; Steinmann B
    J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA sequence analysis of a perinatal lethal osteogenesis imperfecta mutation.
    Patterson E; Smiley E; Bonadio J
    J Biol Chem; 1989 Jun; 264(17):10083-7. PubMed ID: 2470760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII.
    Raff ML; Craigen WJ; Smith LT; Keene DR; Byers PH
    Hum Genet; 2000 Jan; 106(1):19-28. PubMed ID: 10982177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.
    Marini JC; Grange DK; Gottesman GS; Lewis MB; Koeplin DA
    J Biol Chem; 1989 Jul; 264(20):11893-900. PubMed ID: 2745420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.